drugset / Trial / NCT00971295
Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective was to investigate whether multiple-dose administration of eslicarbazepine acetate affects the pharmacokinetics of metformin.
Timeline
- Start
- 2007-10
- Primary completion
- 2007-12
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | Oral |
| Subject | Metformin | Small molecule | 850 mg | — |